LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

Search

Agilent Technologies Inc

Gesloten

SectorGezondheidszorg

126.3 -0.71

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

125.5

Max

127.37

Belangrijke statistieken

By Trading Economics

Inkomsten

34M

339M

Verkoop

37M

1.8B

K/W

Sectorgemiddelde

26.223

49.712

EPS

1.49

Dividendrendement

0.77

Winstmarge

18.474

Werknemers

18,000

EBITDA

44M

500M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+21.93% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.77%

2.36%

Volgende Winsten

26 aug 2026

Volgende dividenddatum

22 jul 2026

Volgende Ex Dividend datum

30 jun 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

4.4B

37B

Vorige openingsprijs

127.01

Vorige sluitingsprijs

126.3

Nieuwssentiment

By Acuity

34%

66%

72 / 342 Rangschikking in Healthcare

Agilent Technologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Over Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
help-icon Live chat